Einige Inhalte auf dieser Seite sind in deutscher Sprache nicht verfügbar und werden automatisch in derzeit verfügbarer Sprache angezeigt.

Cabozantinib

Artikel-Nr.	Packungseinheit	Preis	Vorlaufzeit	Jetzt kaufen
5564-1g	1 g	$179.00	21 Tagen.

Einen günstigeren Preis gefunden? Lassen Sie es uns wissen und wir unterbreiten Ihnen ein besseres Angebot!

Cabozantinib is a dual mechanism inhibitor that targets MET receptor tyrosine kinase and vascular endothelial growth factor receptor 2 (VEGFR2). The drug is used for the treatment of several types of oncological diseases, including renal cell carcinoma (RCC) (including in combination with nivolumab), hepatocellular carcinoma (HCC), differentiated thyroid cancer (DTC), and neuroendocrine tumors (NETs). The compound is also utilized in research to evaluate its efficacy and safety in other disease types, as well as to study mechanisms of therapy resistance.

This product is intended for research use only.

Herunterladen im
ChemDraw-Format

General properties

Appearance:	off-white powder
Molecular weight:	635.60
CAS number:	1140909-48-3 (malate); 849217-68-1
Molecular formula:	C₃₂H₃₀FN₃O₁₀
Solubility:	DMSO
Quality control:	NMR ¹H and HPLC-MS (98+%)
Storage conditions:	24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Desiccate.
Sicherheitsdatenblatt:	herunterladen
	Product specifications